Toshiyuki Oshitari

Prof. Dr. Toshiyuki Oshitari

Department of Ophthalmology, International University of Health and Welfare School of Medicine, 4-3 Kozunomori, Narita 286-8686, Chiba, Japan
+1
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2008 in Eye
Verified
Journal Article
Closed access
Toshiyuki OshitariToshiyuki Oshitari
Toshiyuki Oshitari
KHK Hanawa
K Hanawa
EAE Adachi-Usami
E Adachi-Usami

1 August 2011 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
EOEmi Ooka
Emi Ooka
YMYoshinori Mitamura
Yoshinori Mitamura
TBTakayuki Baba
Takayuki Baba
MKMasayasu Kitahashi
Masayasu Kitahashi
Toshiyuki OshitariToshiyuki Oshitari
Toshiyuki Oshitari
SYShuichi Yamamoto
Shuichi Yamamoto

Verified
Journal Article
Open access
PDF file
Toshiyuki OshitariToshiyuki Oshitari
Toshiyuki Oshitari
Diabetic retinopathy is a tissue-specific neurovascular impairment of the retina in patients with both type 1 and type 2 diabetes. Several pathological factors are involved in the progressive impairment of the interdependence between cells that consist of the neurovascular units (NVUs). The advanced glycation end-products (AGEs) are one of the major pathological factors that cause the impairments of neurovascular coupling in diabetic retinopathy. Although the exact mechanisms for the toxicities of the AGEs in diabetic retinopathy have not been definitively determined, the AGE-receptor of the AGE (RAGE) axis, production of reactive oxygen species, inflammatory reactions, and the activation of the cell death pathways are associated with the impairment of the NVUs in diabetic retinopathy. More specifically, neuronal cell death is an irreversible change that is directly associated with vision reduction in diabetic patients. Thus, neuroprotective therapies must be established for diabetic retinopathy. The AGEs are one of the therapeutic targets to examine to ameliorate the pathological changes in the NVUs in diabetic retinopathy. This review focuses on the basic and pathological findings of AGE-induced neurovascular abnormalities and the potential therapeutic approaches, including the use of anti-glycated drugs to protect the AGE-induced impairments of the NVUs in diabetic retinopathy.

1 June 2012 in Current Diabetes Reviews
Verified
Journal Article
Closed access
PDF file
GBGuzel Bikbova
Guzel Bikbova
Toshiyuki OshitariToshiyuki Oshitari
Toshiyuki Oshitari
ATAyako Tawada
Ayako Tawada
SYShuichi Yamamoto
Shuichi Yamamoto
Diabetes mellitus is a major disease worldwide, and the prevalence of diabetes has risen significantly in the past several decades. Although one of the major complications of diabetic eyes is diabetic retinopathy (DR), corneal diseases can not only develop in diabetic patients but are also difficult to manage. Diabetic neurotrophic keratopathy is a component of diabetic polyneuropathy and is recognized to be the cause of the morbidity of the cornea in diabetic patients. In addition, corneal endothelial cell damage can cause disturbances in the management of proliferative DR before and after surgeries because of endothelial decompensation with bullous keratopathy. However, there have been only a limited number of studies that have focused on the importance of corneal diseases in diabetic patients. This review describes the pathophysiological roles of different factors that have been found to be causative factors of diabetic corneal keratopathy and endothelial cell dysfunction in diabetic patients. In addition, the clinical features of the corneal changes in diabetic patients and recent studies related to the development of therapies for the management of corneal diseases are presented.

1 December 2012 in Ophthalmology
Verified
Journal Article
Closed access
TBTakayuki Baba
Takayuki Baba
AHAkira Hagiwara
Akira Hagiwara
ESEiju Sato
Eiju Sato
MAMiyuki Arai
Miyuki Arai
Toshiyuki OshitariToshiyuki Oshitari
Toshiyuki Oshitari
SYShuichi Yamamoto
Shuichi Yamamoto

27 March 2008 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
Toshiyuki OshitariToshiyuki Oshitari
Toshiyuki Oshitari
SYS Yamamoto
S Yamamoto
NHN Hata
N Hata
SRS Roy
S Roy
Background: Neuronal abnormalities are associated with the pathogenesis of diabetic retinopathy. However, the mechanisms for neuronal cell death in diabetic retinopathy remain unclear. Aim: To determine whether altered expression of Bax, caspase-9 and -3 is associated with degenerative neurons in diabetic retinopathy. Methods: Immunohistochemistry was performed on cryosections obtained from five pairs of normal and five pairs of age-matched diabetic human retinas. Diabetic eyes had no proliferative diabetic retinopathy and no histories of photocoagulation or ocular surgery. In this study, Fluoro-Jade B (FJB) was used as a marker for identification of degenerative neurons. Results: In diabetic retinas, Bax overexpression coexisted with FJB positive signals in the ganglion cell layer (GCL) compared with very low FJB levels in the normal retina. Increased level of the active forms of caspase-9 and -3 expressions coexisted with FJB positive cells in the GCL of diabetic retinas compared with those in normal retinas. Conclusions: Upregulation of Bax, caspase-9 and -3 expression was associated with neuronal degeneration in diabetic retinopathy. The mitochondria- and caspase-dependent cell-death pathway may be, in part, associated with neuronal degeneration in diabetic retinas.